Outsourced Pharma Capacity Update Videos - Fill/Finish

  1. IDT Biologika Capacity Update April 2025: Fill/Finish 4/25/2025

    Watch as Senior Key Account Manager, Dr. Jürgen Lübbehusen highlights IDT Biologika´s overall fill-finish capabilities and capacities, with a focus on our ability to help meet your complex needs.

  2. FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Fill/Finish 4/25/2025

    Executive Director of Technology and Business Development for Drug Product and Finished Goods, Henrik Herrmann, shares an update on the current and future state of FDB’s capabilities.

  3. Argonaut Capacity Update April 2025: Fill/Finish 4/25/2025

    Advance your clinical and commercial programs with expert aseptic fill finish and formulation services across vials, cartridges, and syringes, all in state-of-the-art, EU Annex 1-compliant facilities.

  4. Lonza Capacity Update January 2025: Fill/Finish 1/31/2025

    Discover how Lonza Biologics’ end-to-end Drug Product capabilities support the full lifecycle of biologics, seamlessly integrated with their extensive drug substance network across diverse modalities.

  5. Lifecore Biomedical Capacity Update January 2025: Fill/Finish 1/31/2025

    Join Darren Hieber as he presents an overview of Lifecore Biomedical’s newly expanded capabilities, designed to meet the growing demands of innovative therapeutics.

  6. Fill/Finish Capacity Update January 2025 1/31/2025

    From early development through small-scale production to full-scale global commercialization, our proven track record with international regulatory agencies underscores our ability to navigate complex requirements with precision.

  7. FUJIFILM Diosynth Biotechnologies Capacity Update January 2025: Fill/Finish 1/31/2025

    Get an exclusive update on FDB’s current and future Drug Product and Finished Goods capabilities, and discover how their end-to-end CDMO services can support your next project.

  8. Alcami Capacity Update January 2025: Fill/Finish 1/31/2025

    Equipped with advanced isolator and Restricted Access Barrier Systems (RABs) technologies, our aseptic filling facilities feature multiple filling lines capable of producing liquid and lyophilized vials as well as prefilled syringes.

  9. SMC Ltd. Capacity Update October 2024: Fill/Finish 10/25/2024

    Partner with us to access the critical services that drive your success — supporting everything from technical and development batches to Phase 1 clinical trials and product launch.

  10. PCI Pharma Services Capacity Update October 2024: Fill/Finish 10/25/2024

    Jeff Clement, Executive Director of Technical Sales Drug Product Development and Manufacturing, outlines our global sterile fill-finish and lyophilization capabilities, investments, and expansions.